Rebus Holdings Inc (RBSH)

[KeepItRealistic]

Already answered by PB

“Royalty Partners and money upfront in exchange for a cut of the revenue from the drug. Since royalties have value, they can be bought and sold. Sometimes funds buy the royalties.

Recently, Dendreon (Nasdaq: DNDN) sold the royalty it was owed on sales of Merck's (NYSE: MRK) Victrelis for $125 million to CPP Investment Board.”